Article Listing - AstraZeneca’s CEO defends company’s stance in Bloomberg interview

WELLCOME SELL-OFF SANCTIONED

11 May 1992

The Wellcome Trust has received the sanction of the UK High Court to reduce its stake in the UK-based pharmaceutical...

1st QTR PROFIT UP 9% AT SMITH & NEPHEW

11 May 1992

In the first quarter of 1992 Smith & Nephew made sales of L 201.1 million ($357.2 million), up 11% on...

CARDIOXANE APPROVED IN DENMARK

11 May 1992

EuroCetus has received marketing approval in Denmark for its anticancer adjuvant product Cardioxane (desrazoxane). The product was first launched in...

AUTISM TREATMENTS COMPARED

11 May 1992

A comparative study looking at the effects of the tricyclic antidepressants clomipramine and desipramine in children with autism, which is...

NEW ARAB DRUG COMPANY FOUNDED

11 May 1992

The Arab Pharmaceutical Industries Company was founded in Tunis on April 13, according to a report from the TAP news...

MIXED RESULTS FROM LATEST US QUARTERLIES

11 May 1992

Du Pont and Eastman Kodak were among the companies reporting first-quarter 1992 financial results in the past week. Both had...

REGENERON BEGINS CNTF TRIALS

11 May 1992

Regeneron Pharmaceuticals has now begun clinical trials in the USA with its recombinant ciliary neurotrophic factor (CNTF). This orphan drug...

FIDIA'S GM1 AND PARKINSONISM

11 May 1992

Italian company Fidia's ganglioside compound GM1 may be effective in treating and reversing the degeneration of neurons in Parkinson's disease,...

PHARMA PRODUCTION IN VIETNAM

11 May 1992

Vietnam's Minister of Health, Pham Song, has said that the country is still having to import up to 70% of...

CIBA-GEIGY SEEKS FOREIGN INVESTORS

11 May 1992

Swiss drugs major Ciba-Geigy will make strenuous efforts to gain more foreign investors as shareholders, according to supervisory council president,...

Showing 94161-94170 of 95569 articles